Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Allison Fulton has joined its Washington, D.C. office as a partner in the Life Sciences and FDA team. Fulton joins Sheppard Mullin from Sidley Austin LLP.
“2018 was another busy year for Sheppard Mullins Washington, D.C. office. We added 20 highly talented attorneys in numerous practice areas,” said Jon W. Newby, vice-chairman of Sheppard Mullin. “As our newest partner, Allison brings a wealth of practical guidance and a deep understanding of the FDA, which make her incredibly valuable to our clients. Were thrilled shes joined us.”
Commenting on Fultons addition, Life Sciences and FDA team leader Lorna L. Tanner said, “Our cross-practice Life Sciences and FDA team works with clients on a vast range of strategic matters “ not the least of which is helping them with a variety of FDA issues. Allison is an outstanding addition to our team and will hit the ground running.”
Fulton added, “Im excited to join Sheppard Mullin and am particularly impressed with the firm’s consistent growth year-over-year, as well as its strong footprint in California. I look forward to collaborating with my new colleagues to help clients avoid and resolve FDA challenges and effectively navigate the increasingly complex regulatory environment.”
WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe to the Global Banking & Finance Review Newsletter for FREE Get Access to Exclusive Reports to Save Time & Money
By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
With extensive experience representing domestic and international pharmaceutical, medical device, food, dietary supplement and cosmetic companies, Fulton advises companies of all sizes facing an array FDA regulatory matters. For example, she helps companies comply with good manufacturing practice (GMP) regulations, prepare for FDA inspections and respond to administrative actions, manage and remediate product safety issues, and generate strategies for product authorization and promotion. She advises innovative medical technology companies on novel issues, including regulatory strategies in digital health and precision medicine, and provides FDA regulatory counsel on acquisitions of life science companies and other transactions involving medical technology companies. She also has led numerous internal investigations involving allegations of off-label promotion, healthcare fraud and abuse, and violations of data integrity requirements. In addition to her active client practice, Fulton focuses her pro bono work on helping veterans obtain benefits for service-connected disabilities.
Fulton earned a J.D., with honors, from the University of Texas School of Law, where she was the managing editor of the Texas Intellectual Property Law Journal, and a B.S. in Industrial Engineering from Northwestern University.
Sheppard Mullin has nearly 100 attorneys based in its Washington, D.C. office. The firm’s Life Sciences and FDA team includes more than 60 attorneys firmwide.
About Sheppard, Mullin, Richter & Hampton LLP
Sheppard Mullin is a full-service Global 100 firm with more than 850 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, industry-leading companies have turned to Sheppard Mullin to handle corporate and technology matters, high-stakes litigation and complex financial transactions. In the U.S., the firm’s clients include more than half of the Fortune 100. For more information, please visit www.sheppardmullin.com.